Dr Ahmed Elshashai
Principal Investigator
Key Appointments:
Former Medical Director (UK), Velocity Clinical Research
Former Clinical Research Physician at MeDiNova (currently Accellacare, ICON)
Former Co-founder & Chief Investigator, Egin Research
Expert Member, Brighton & Sussex Research Ethics Committee
Years of Experience:
10+ years in clinical research across CNS, psychiatry and internal medicine
Therapeutic Areas (CNS & Psychiatry):
Generalised Anxiety Disorder, Treatment-Resistant Depression, Major Depressive Disorder, PTSD, Migraine, Chronic Pain (Neurology-linked indications)
Drug Classes & Modalities:
Psychedelics (MM120/5-HT2A agonists), novel neuroplasticity agents, antidepressants, anxiolytics, buccal film formulations, migraine therapeutics, anti-inflammatory agents, biologics, respiratory therapeutics (supporting CNS comorbidity research)
Clinical Trials Experience
PI/Sub-I on 62 clinical trials across Phases I–IV, including:
Multiple Phase 2–3 psychiatric trials in GAD, MDD, TRD
Schedule 1 protocols involving novel CNS compounds
National Chief Investigator for a large COPD behavioural/intervention study
PI experience across psychiatry, migraine, pain-adjacent, respiratory and inflammatory conditions
Extensive experience in psychiatric rating scales
